Skip to main content
    S

    Seer Inc (SEER)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.48
    -0.09 (-5.73%)

    Market Cap: $87.63M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Seer Inc (SEER) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    SEER is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, SEER reported EPS of -$0.25, above the -$0.26 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    60%(15/25)
    Avg Surprise
    +4.06%
    Streak
    1 Q

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.22
    Range-$0.22 - -$0.22
    4 analysts
    Revenue Consensus
    $5.20M
    Range$4.12M - $6.30M
    4 analysts
    Reports May 11, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.27
    Range-$0.28 - -$0.25
    2 analysts
    EPS Revisions
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.25-6.0%
    60d ago-$0.25-6.0%
    30d ago-$0.25-6.0%
    7d ago-$0.25-6.0%
    Current-$0.27
    Revenue Consensus
    $4.15M
    Range$3.60M - $4.70M
    2 analysts

    Next Report

    SEER has an expected report date of Feb 24, 2027.

    SEER Earnings Call

    The latest SEER earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 25 quarters below that had an estimate, SEER beat 15, missed 8 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $3.98M, down 3.4% from $4.12M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.25-$0.26-$0.27 - -$0.25+3.85%BeatN/A20 up, 2 downNov 10, 2026$3.98M
    Jun 30, 2026-$0.31-$0.27-$0.29 - -$0.25-14.81%MissN/A21 up, 0 downAug 11, 2026$3.10M
    Mar 31, 2026-$0.30-$0.29-$0.31 - -$0.28-3.45%MissN/A21 up, 0 downMay 13, 2026$2.79M
    Dec 31, 2025-$0.29-$0.31N/A+6.45%BeatN/A11 up, 0 downFeb 26, 2026$4.20M
    Sep 30, 2025-$0.32-$0.30-$0.30 - -$0.30-6.67%MissN/A11 up, 0 downNov 6, 2025$4.12M
    Jun 30, 2025-$0.33-$0.37-$0.39 - -$0.35+10.81%BeatN/A21 up, 1 downAug 6, 2025$4.05M
    Mar 31, 2025-$0.34-$0.36-$0.39 - -$0.35+5.56%BeatN/A30 up, 1 downMay 13, 2025$4.21M
    Dec 31, 2024-$0.37-$0.39-$0.41 - -$0.36+4.42%BeatN/A30 up, 3 downFeb 27, 2025$4.00M
    Sep 30, 2024-$0.35-$0.31-$0.35 - -$0.24-12.90%MissN/A30 up, 0 downNov 6, 2024$4.03M
    Jun 30, 2024-$0.35-$0.36-$0.37 - -$0.35+2.78%BeatN/A30 up, 0 downAug 8, 2024$3.07M
    Mar 31, 2024-$0.32-$0.30-$0.34 - -$0.27-6.67%MissN/A31 up, 0 downMay 8, 2024$3.07M
    Dec 31, 2023-$0.28-$0.37-$0.41 - -$0.34+24.32%BeatN/A30 up, 0 downFeb 29, 2024$4.44M
    Sep 30, 2023-$0.33-$0.40-$0.44 - -$0.34+17.50%BeatN/A30 up, 0 downNov 7, 2023$4.16M
    Jun 30, 2023-$0.37-$0.40-$0.43 - -$0.35+7.50%BeatN/A40 up, 0 downAug 8, 2023$4.01M
    Mar 31, 2023-$0.38-$0.38-$0.42 - -$0.350.00%In lineN/A40 up, 0 downMay 9, 2023$4.05M
    Dec 31, 2022-$0.36-$0.43-$0.46 - -$0.39+16.28%BeatN/A40 up, 1 downMar 2, 2023$4.61M
    Sep 30, 2022-$0.38-$0.39-$0.42 - -$0.36+2.56%BeatN/A40 up, 0 downNov 8, 2022$3.96M
    Jun 30, 2022-$0.37-$0.39-$0.42 - -$0.34+5.13%BeatN/A40 up, 0 downAug 9, 2022$3.62M
    Mar 31, 2022-$0.38-$0.39-$0.41 - -$0.38+2.56%BeatN/A30 up, 0 downMay 4, 2022$3.31M
    Dec 31, 2021-$0.32-$0.32-$0.36 - -$0.290.00%In lineN/A4N/AFeb 28, 2022$3.07M
    Sep 30, 2021-$0.30-$0.29-$0.29 - -$0.28-3.45%MissN/A4N/ANov 9, 2021$2.15M
    Jun 30, 2021-$0.27-$0.28-$0.28 - -$0.27+3.57%BeatN/A4N/AAug 12, 2021$1.33M
    Mar 31, 2021-$0.27-$0.20-$0.25 - -$0.12-35.00%MissN/A4N/AMay 10, 2021$62000
    Dec 31, 2020-$0.54-$0.48-$0.48 - -$0.48-12.50%MissN/A1N/AMar 29, 2021$336000
    Sep 30, 2020-$0.12-$0.73N/A+83.56%BeatN/AN/AN/ADec 4, 2020$72000
    Jun 30, 2020-$0.06N/AN/AN/AN/AN/AN/AN/ASep 25, 2020$71000
    Sep 30, 2019-$0.63N/AN/AN/AN/AN/AN/AN/ADec 31, 2019N/A
    Last 27 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.28, after -$1.39 the year before. It was -$1.35 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.28N/A
    Dec 31, 2024-$1.39N/A
    Dec 31, 2023-$1.36N/A
    Dec 31, 2022-$1.49N/A
    Dec 31, 2021-$1.16N/A
    Dec 31, 2020-$1.35N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,500 words across 6 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20264,4636
    2026Q2Jun 30, 20264,5116
    2026Q1Mar 31, 20265,2086
    2025Q4Dec 31, 20255,5435
    2025Q3Sep 30, 20254,6905
    2025Q2Jun 30, 20255,0286
    2025Q1Mar 31, 20254,2575
    2024Q4Dec 31, 20246,4327

    2026Q3 Earnings Call

    Opening remarks

    Marissa Bych Gilmartin Group Representative Thank you. Earlier today, Seer released financial results for the quarter ended September 30, 2026. If you have not received this news release, or if you would like to be added to the company's distribution list, please send an email to investor@seer.bio. In addition, during today's conference call, we will be referencing a slide presentation that can be accessed on the Events and Presentations section of Seer's Investor Relations website. Participating today from Seer are Omid Farokhzad, Chief Executive Officer and Chair of the Board, and Charles Endweiss, Treasurer, Principal Financial Officer, and Principal Accounting Officer. Before we begin, I would like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. Additional information regarding these risks and uncertainties appears in the section titled Forward-Looking Statements in the press release we issued today. For a more complete list and description, please see the Risk Factors section of the company's quarterly report on Form 10-Q for the quarter ended September 30, 2026, and in its other filings with the Securities and Exchange Commission. Except as required by law, Seer disclaims any intention or obligation to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise. This conference call contains time-sensitive information and is accurate only as of the live broadcast today. With that, I would like to turn the call over to Omid.

    Omid Farokhzad Chief Executive Officer and Chair of the Board Thank you, Marissa, and thank you all for joining us this afternoon. This quarter, our customers continued to demonstrate what Proteograph makes possible, from new biological discoveries in population-scale studies to emerging applications in AI. Established customers continue to purchase consumables, and new large biopharma customers adopted the Proteograph Product Suite for use in their own laboratories. These developments reinforce my conviction in the value of our technology and the business opportunity ahead for Seer. Our opportunity is to make deep, unbiased proteomics a routine part of research programs that require a more complete understanding of biology. Proteograph substantially expands what researchers can learn from mass spectrometry while allowing them to use existing LC-MS infrastructure. As this value becomes clearer across more applications, we have the opportunity to expand both our customer base and the use of the platform within each account. The business model connects directly to that use. Each additional sample processed with Proteograph requires assay consumables. A successful study can lead to a larger cohort, follow-up research, or adoption by another team within the same institution.

    Frequently Asked Questions About SEER

    When is SEER's next earnings date?

    SEER's next earnings report is expected for Feb 24, 2027.

    Did SEER beat earnings estimates last quarter?

    Yes. SEER reported EPS of -$0.25 for the quarter ended Sep 30, 2026, above the -$0.26 estimate, a 3.85% surprise.

    What EPS do analysts expect from SEER next quarter?

    The consensus EPS estimate for SEER for the quarter ending Dec 31, 2026 is -$0.22 from 4 analysts, with estimates from -$0.22 to -$0.22.

    How often does SEER beat earnings estimates?

    SEER beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +0.77%.